Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX)

CUSIP: 22053A107

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock, par value $0.0001 par value
Shares outstanding
55,541,178
Total 13F shares
15,442,796
Share change
+3,995,141
Total reported value
$714,739,484
Price per share
$46.30
Number of holders
82
Value change
+$184,954,170
Number of buys
65
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 22053A107?
CUSIP 22053A107 identifies QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX) as of Q2 2020

As of 30 Jun 2020, Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,442,796 shares. The largest 10 holders included EPIQ Capital Group, LLC, Capital Research Global Investors, Capital World Investors, Capital International Investors, SC US (TTGP), LTD., BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, STATE STREET CORP, and Alphabet Inc.. This page lists 82 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.